Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Clin Pharmacol. 2007 May;63(5):479-83. Epub 2007 Mar 8.

Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients.

Author information

  • 1Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand. srsomcha@medicine.psu.ac.th

Abstract

OBJECTIVE:

To investigate the effect of efavirenz on the ketoconazole pharmacokinetics in HIV-infected patients.

METHODS:

Twelve HIV-infected patients were assigned into a one-sequence, two-period pharmacokinetic interaction study. In phase one, the patients received 400 mg of ketoconazole as a single oral dose on day 1; in phase two, they received 600 mg of efavirenz once daily in combination with 150 mg of lamivudine and 30 or 40 mg of stavudine twice daily on days 2 to 16. On day 16, 400 mg of ketoconazole was added to the regimen as a single oral dose. Ketoconazole pharmacokinetics were studied on days 1 and 16.

RESULTS:

Pretreatment with efavirenz significantly increased the clearance of ketoconazole by 201%. C(max) and AUC(0-24) were significantly decreased by 44 and 72%, respectively. The T ((1/2)) was significantly shorter by 58%.

CONCLUSION:

Efavirenz has a strong inducing effect on the metabolism of ketoconazole.

PMID:
17345073
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk